ZNF17 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.598500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.700800E-01
Normal-vs-Stage2
6.958100E-02
Normal-vs-Stage3
1.497420E-01
Normal-vs-Stage4
9.971400E-01
Stage1-vs-Stage2
8.345600E-02
Stage1-vs-Stage3
1.316210E-01
Stage1-vs-Stage4
7.173200E-01
Stage2-vs-Stage3
2.417200E-01
Stage2-vs-Stage4
3.587600E-02
Stage3-vs-Stage4
5.756200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.139190E-01
Normal-vs-AfricanAmerican
3.076200E-01
Normal-vs-Asian
7.251500E-02
Caucasian-vs-AfricanAmerican
9.968000E-01
Caucasian-vs-Asian
9.154000E-02
AfricanAmerican-vs-Asian
2.790800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.721600E-02
Normal-vs-Female
1.198820E-01
Male-vs-Female
4.483000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.811200E-01
Normal-vs-Age(41-60Yrs)
5.788400E-01
Normal-vs-Age(61-80Yrs)
7.591900E-02
Normal-vs-Age(81-100Yrs)
3.343600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.327000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.863800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.842800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.178600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.290160E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.563000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.435700E-02
Normal-vs-Daily Drinker
8.712000E-02
Normal-vs-Weekly Drinker
1.045230E-01
Normal-vs-Occasional Drinker
5.252200E-01
Normal-vs-Social Drinker
4.639000E-01
Non Drinker-vs-Daily Drinker
6.439400E-01
Non Drinker-vs-Weekly Drinker
7.064400E-01
Non Drinker-vs-Occasional Drinker
9.308500E-02
Non Drinker-vs-Social Drinker
2.520200E-01
Daily Drinker-vs-Weekly Drinker
9.795200E-01
Daily Drinker-vs-Occasional Drinker
1.915350E-01
Daily Drinker-vs-Social Drinker
4.388600E-01
Weekly Drinker-vs-Occasional Drinker
2.094800E-01
Weekly Drinker-vs-Social Drinker
4.427800E-01
Occasional Drinker-vs-Social Drinker
5.953600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.869200E-01
Normal-vs-Grade 2
6.651200E-01
Normal-vs-Grade 3
6.540200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.749200E-01
Grade 1-vs-Grade 3
5.805400E-01
Grade 1-vs-Grade 4
2.869200E-01
Grade 2-vs-Grade 3
8.081400E-01
Grade 2-vs-Grade 4
6.651200E-01
Grade 3-vs-Grade 4
6.540200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.213600E-02
Normal-vs-NonDiabetic
7.423900E-02
Diabetic-vs-NonDiabetic
3.660200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.907800E-02
Normal-vs-NoPancreatitis
8.085600E-02
Pancreatitis-vs-NoPancreatitis
3.330000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.050970E-01
Normal-vs-N1
8.314200E-02
N0-vs-N1
8.664000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.437000E-01
Normal-vs-TP53-NonMutant
3.423400E-01
TP53-Mutant-vs-TP53-NonMutant
2.191000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
